Heng, Richard,Hoegenauer, Elizabeth Kate,Koch, Guido,Pulz, Robert Alexander,Vulpetti, Anna,Waelchli, Rudolf
申请号:
AU2012282229
公开号:
AU2012282229A1
申请日:
2012.07.07
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention describes new pyrrolo pyrimidine derivatives and pharmaceutically acceptable salts thereof which appear to interact with Bruton's tyrosine kinase (Btk). Accordingly, the novel pyrrolo pyrimidines may be effective in the treatment of autoimmune disorders, inflammatory diseases, allergic diseases, airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), transplant rejection, cancers e.g. of hematopoietic origin or solid tumors.